Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Emanuelli, Rodolfo
DOB:	17-JUN-1984 (Age: 41)
Gender:	male
Address:	Contrada Adelmo, 20 Piano 5 31027 Spresiano (Italy)
ID:	7624-273065-3 (ECI)

Report
Date:	22-MAR-2020

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro di Medicina Viale della Repubblica 10b 31020 Villorba (Italy)

Specimen
Collected:	22-MAR-2020

Chemistry

Test	22-MAR-2020	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.4	4.8 - 5.9	%
Glucose [Mass/volume] in Blood	130.1 H	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	7.9	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	1.2	0.6 - 1.2	mg/dL
Calcium [Mass/volume] in Blood	9.4	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	142.9	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.5	3.5 - 5.0	mmol/L
Chloride [Moles/volume] in Blood	107.4 H	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	24.2	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	249.4 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	214.1 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	174.3 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	32.2 L	40 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	16.5	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows impaired fasting glucose with normal HbA1c, suggesting possible early glucose metabolism disturbance. Lipid profile indicates significant dyslipidemia (high total cholesterol, LDL, triglycerides, and low HDL), increasing cardiovascular risk. Renal function and electrolytes are within normal limits except for mildly elevated chloride. Urine microalbumin/creatinine is normal. Recommend further evaluation for metabolic syndrome and cardiovascular risk management.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows impaired fasting glucose with normal HbA1c, suggesting possible early glucose metabolism disturbance. Lipid profile indicates significant dyslipidemia (high total cholesterol, LDL, triglycerides, and low HDL), increasing cardiovascular risk. Renal function and electrolytes are within normal limits except for mildly elevated chloride. Urine microalbumin/creatinine is normal. Recommend further evaluation for metabolic syndrome and cardiovascular risk management.